166 related articles for article (PubMed ID: 6988345)
1. Mechanism of action of the folate blocker diaminodiphenylsulfone (dapsone, DDS) studied in E. coli cell-free enzyme extracts in comparison to sulfonamides (SA).
Seydel JK; Richter M; Wempe E
Int J Lepr Other Mycobact Dis; 1980 Mar; 48(1):18-29. PubMed ID: 6988345
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory activity and mode of action of diaminodiphenylsulfone in cell-free folate-synthesizing systems prepared from Mycobacterium lufu and Mycobacterium leprae. A comparison.
Kulkarni VM; Seydel JK
Chemotherapy; 1983; 29(1):58-67. PubMed ID: 6339181
[TBL] [Abstract][Full Text] [Related]
3. Mechansism of action of DDS.
Hasting RC
Int J Lepr Other Mycobact Dis; 1980 Mar; 48(1):65. PubMed ID: 6988348
[No Abstract] [Full Text] [Related]
4. Dapsone, folate synthesis and M. leprae.
Chatterjee BR
Indian J Lepr; 1990; 62(4):459-66. PubMed ID: 2086681
[No Abstract] [Full Text] [Related]
5. In vitro and in vivo experiments with the new inhibitor of mycobacterium leprae brodimoprim alone and in combination with dapsone.
Seydel JK; Wempe EG; Rosenfeld M; Jagannathan R; Mahadevan PR; Dhople AM
Arzneimittelforschung; 1990 Jan; 40(1):69-75. PubMed ID: 2187440
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo activity of K-130, a dihydrofolate reductase inhibitor, against Mycobacterium leprae.
Dhople AM
Arzneimittelforschung; 1999 Mar; 49(3):267-71. PubMed ID: 10219472
[TBL] [Abstract][Full Text] [Related]
7. Bacterial growth kinetics of Escherichia coli and mycobacteria in the presence of brodimoprim and metioprim alone and in combination with sulfamerazine and dapsone (VI).
Seydel JK; Wempe EG; Rosenfeld M
Chemotherapy; 1983; 29(4):249-61. PubMed ID: 6347548
[TBL] [Abstract][Full Text] [Related]
8. Bacterial growth kinetics of "M. lufu" in the presence and absence of various drugs alone and in combination. A model for the development of combined chemotherapy against M. leprae?
Seydel JK; Wempe EG
Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):20-30. PubMed ID: 7042611
[TBL] [Abstract][Full Text] [Related]
9. One-carbon requirements of Mycobacterium leprae: need for the folate pathway.
Wheeler PR
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):445-50. PubMed ID: 1474283
[No Abstract] [Full Text] [Related]
10. In vitro and in vivo results of brodimoprim and analogues alone and in combination against E. coli and mycobacteria.
Seydel JK
J Chemother; 1993 Dec; 5(6):422-9. PubMed ID: 8195833
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of dihydropteroate synthetase from Escherichia coli by sulfones and sulfonamides.
McCullough JL; Maren TH
Antimicrob Agents Chemother; 1973 Jun; 3(6):665-9. PubMed ID: 4597736
[TBL] [Abstract][Full Text] [Related]
12. Drug resistance of Mycobacterium leprae, particularly to DDS.
Rees RJ
Int J Lepr Other Mycobact Dis; 1967; 35(4):625-38. PubMed ID: 4173566
[No Abstract] [Full Text] [Related]
13. Dapsone resistance in Mycobacterium leprae.
Gillis TP; Williams DL
Lepr Rev; 2000 Dec; 71 Suppl():S91-5. PubMed ID: 11201896
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with brodimoprim and dapsone, against Mycobacterium leprae.
Dhople AM
Int J Antimicrob Agents; 1999 Aug; 12(4):319-23. PubMed ID: 10493608
[TBL] [Abstract][Full Text] [Related]
15. In vivo activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with dapsone, against Mycobacterium leprae.
Dhople AM
Int J Antimicrob Agents; 2002 Jan; 19(1):71-4. PubMed ID: 11814771
[TBL] [Abstract][Full Text] [Related]
16. New mechanism for a classic folate inhibitor.
Brown HA
Nat Chem Biol; 2008 Oct; 4(10):581-2. PubMed ID: 18800042
[No Abstract] [Full Text] [Related]
17. Sulfonamide structure-activity relationship in a cell-free system. Correlation of inhibition of folate synthesis with antibacterial activity and physicochemical parameters.
Miller GH; Doukas PH; Seydel JK
J Med Chem; 1972 Jul; 15(7):700-6. PubMed ID: 4557856
[No Abstract] [Full Text] [Related]
18. Crystal structure of Mycobacterium tuberculosis 7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action.
Baca AM; Sirawaraporn R; Turley S; Sirawaraporn W; Hol WG
J Mol Biol; 2000 Oct; 302(5):1193-212. PubMed ID: 11007651
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes.
Roychowdhury S; Vyas PM; Reilly TP; Gaspari AA; Svensson CK
J Pharmacol Exp Ther; 2005 Jul; 314(1):43-52. PubMed ID: 15784651
[TBL] [Abstract][Full Text] [Related]
20. Permeability of Mycobacterium leprae to dapsone: alteration by purification procedures.
Prabhakaran K; Harris EB; Kirchheimer WF
Lepr India; 1981 Apr; 53(2):160-2. PubMed ID: 6789004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]